0% found this document useful (0 votes)
53 views6 pages

Niflec: Usage, Side Effects, and Precautions

This document summarizes the composition, actions, indications, usage, dosage, precautions, and side effects of NIFLEC. NIFLEC is used to clean the intestinal tract prior to endoscopy or surgery. It contains macrogol 4000, sodium sulfate, sodium hydrogen carbonate, sodium chloride, and potassium chloride. When taken in sufficient volume, it increases colon volume through osmosis and peristalsis to produce liquid stool. Precautions are advised for patients with medical issues, and side effects can include nausea, vomiting, and in rare cases anaphylaxis.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
53 views6 pages

Niflec: Usage, Side Effects, and Precautions

This document summarizes the composition, actions, indications, usage, dosage, precautions, and side effects of NIFLEC. NIFLEC is used to clean the intestinal tract prior to endoscopy or surgery. It contains macrogol 4000, sodium sulfate, sodium hydrogen carbonate, sodium chloride, and potassium chloride. When taken in sufficient volume, it increases colon volume through osmosis and peristalsis to produce liquid stool. Precautions are advised for patients with medical issues, and side effects can include nausea, vomiting, and in rare cases anaphylaxis.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

NIFLEC

COMPOSITION
One sachet (137.155 g) contains :
Macrogol 4000 118.000 g
Sodium sulfate 11.37 g
Sodium hydrogen carbonate 3.37 g
Sodium chloride 2.930 g
Potassium chloride 1.485 g

ACTIONS
When sufficient volume of PEG is taken, it leads to an increase in volume in the colon. This
distends the colon and there by stretch the receptors resulting in increased peristaltic
movements. This products voluminous liquid stool.

The Sodium Chloride, Sodium Sulphate, Potassium Chloride and Sodium Bicarbonate salts
prevents both loss and net absorption of ions from the body.

INDICATION
Clean the remains in the intestinal tracts, as initial action prior to large intestine endoscopy and
surgery.

METHOD OF USAGE AND DOSAGE


Dilute one sachet of drug into 2 liters water to make solution.
Normally for one time usage, an adult takes the solution of 4 liters with drinking rate of about 1
liter each hour. However, stop taking the drug if the excretion fluid is already clear. The dosage
must not exceed 4 liters.
As initial Action Prior to Large Intestine Endoscopy

Administered on the same day of examination : do not take breakfast on the same day
(1) (only drinking is allowed in order to add body fluid), administration commences 4 hours
prior to the scheduled examination.

Administered one day prior to the day examination : fasting after dinner at the previous
night (only drinking is allowed in order to add body fluid), administration commences 1
(2)
hour after dinner. However, food with little waste must be taken for breakfast and lunch,
and liquid food instead of solid food for dinner.

As Initial Action Prior to Large Intestine Surgery


Fasting should commence after lunch on the day of surgery (only drinking is allowed in order to
add body fluid), then administration of this drug commences after more than about 3 hours after
lunch.

PRECAUTION
1. This drug should be administered with caution to the following patients :
a. Patients suffering from angina pectoris, myocardial infarction (with the administration of this
drug, the body temperature may decline, that sometimes resulted in chest pain).
b. Patients with renal function disorder (sometimes it may induce nausea).

2. Basic important things to note

a. Sometimes it may result in Mallory Weis syndrome, tiny holes in the intestinal tract,
followed by bleeding large intestine inflammation, therefore, in administering this drug, the
following must be taken into notice :
Mallory Weis syndrome will appear due to the increasing pressure in the stomach or
nausea, therefore avoid administering this drug within a short period of time
(administer this drug about 1 liter per hour).
The contraction in the intestinal tract or the detention of this drug and the contents of
intestines may cause nausea, that will result in such syndromes.
Tiny holes at the intestinal tract and bleeding large intestine inflammation are caused
by the increasing pressure in the intestinal tract, thus at the time of contraction in the
intestinal tract or the detention of remaining food in the intestinal tract, this drug
should be administered with caution.
Drug is administered after bowel movement on the previous day prior to the
administration of drug or prior to the administration of drug on the same day.
Avoid administering this drug within a short period of time (administer this drug about
1 liter per hour).
If one liter has been administered, but there is no bowel movement, first ensure that
there is no nausea or abdominal pain before administration of this drug is continued,
while keep monitoring bowel movements.
Caution should be taken in administering this drug for patients wit cavity in the
intestinal tract, because development of tiny holes in the intestinal tract has been
reported due to the increased pressure in the intestinal tract.
b. If other ingredients or aromatic materials are added into the solution of this drug, this will
change the osmosis pressure and electrolyte density, and it will probably result in
inflammable gas produced by bacteria in the intestine, thus such materials are prohibited.
c. If the patient applies this drug at home, the following should be taken into notice.
In case of side effect, it will be difficult to handle, thus it is warned not to use the drug
while alone.
Drink should be done slowly and it is warned to take notice of the initial syndromes of
anaphylaxis.
Give detail of the side effects of using this drug, such as syndromes of the digestive
tract (nausea, abdominal pain, and others), shock anaphylaxis, and it should be
warned that in case of any of the syndromes, stop using this drug and seek medical
assistance.
d. Administration of drug to patient who is using insulin or other diabetes drugs :
For patients who is controlling blood sugar by insulin or other diabetes drug, avoid
administering this drug prior to the day of examination.
The drug should be given on the day of examination under strict supervision.
Insulin or other diabetes drugs should be administered after meal on the day of
examination (because during the period of food control, it is worried that low blood
sugar condition may arise).
e. Effect on absorption of other drugs :
Administration of this drug may probably cause the impediment in absorbing other
drugs.
This drug may also cause problems for patient who is taking clinical test, this drugs
must be administered in hospital under strict supervision.

3. Administration of drug to elderly. In general, the biological function of the elderly has dropped,
thus the administration of drug must be slowed down. Drug must be given under strict
supervision.

4. Administration of drug to pregnant women, delivering mothers, nursing mothers and others.

a. This drug is only administered to pregnant women or those with pregnancy probability,
when it is determined that the advantages in treatment exceed the potential risk.
b. Safety in the administration of this drug to pregnant women is still uncertain.

5. Administration of drug to children


Safety in the administration of this drug is still uncertain.

SIDE EFFECT
1. Shock, anaphylaxis

a. This drug must be under strict supervision due to the probability of shock and anaphylaxis.
b. The drug must be stopped and appropriate action should be taken in case of symptoms
such as paleness, declining blood pressure, vomiting, continued nausea, anxiety,
dizziness, feeling cold, rash, respiratory problems, swelling on the face, etc.

2. Tiny holes in the intestinal tract

a. This drug must be administered under strict supervision because tiny holes may develop in
the intestinal tract.
b. Drug must be stopped and appropriate actions must be taken when abnormal symptom is
detected.

3. Heavy vomiting which results in low sodium vomiting syndrome may cause consciousness
problem, and others.
In case of such syndrome, appropriate actions must be given, such as compensation of
electrolyte fluid and others.

4. Other side effects :

Above 5% or unclear
0.1% - below 5% Below 0.1%
percentage

Oversensitive Measles, rash

Central and
Unsteadiness,
peripheral nerve
feeling cold
system

Psychotropic nerve
Insomnia
system
Abdominal swelling,
Noise in the
Digestive system nausea, abdominal Anus pain
stomach
pain, vomiting

Respiratory system Chest pain

Syndromes of
low blood
sugar, high
Internal secretion Positive ketone
blood
system body
pressure,
increase of
uric acid

Increase of GOT,
Increase of GPT,
Increase of LDH,
Increase of
Bilirubin,
Liver
Increase of protein,
Decrease of
Protein, Increase of
alkali postage

Protein in urine
Kidney
being positive

Sharp
increase of
leukocytes;
increase of
Blood Leukopenia sodium in
blood serum,
decline of
sodium in
blood serum

Headache, dry Fever,


mouth, frequent shivering,
Others Fatigue
bowel movements, feeling of
heat in chest heavy head

WARNING IN USAGE
1. Method of preparation
Dissolved one sachet of this drug in water about 2 liters, then given to the patient orally.
2. During preparation
The solution of this drug must not be added with other composition or aromatic substances.
3. During storage
After being dissolved, it is better to use it directly, otherwise, keep it in the refrigerator and it
must be used within 48 hours.
4. Length of time in administering drug
Move the solution (about 180 ml) into the glass. Within one hour drink about 6 glasses (about
one liter).
5. During administration of drug

In many cases, bowel movement usually commences after administration of about one liter
solution.
Administration of this drug is continued until the excretion fluid becomes clear.
Maximum dosage is 4 liters.
After the administration of drug is completed, the patient will still have a few bowel
movements.
If there is still no bowel movement after administration of 2 liters solution, the drug must be
stopped and may only be re-administered after there is no nausea, vomiting, abdominal
pain and after bowel movement.

6. Purpose of usage
Please note that this drug is not suitable for initial actions prior to intestine X-ray inspection
with Barium injection.

CONTRAINDICATIONS
Do not administered to the following patients :
1. Symptoms of digestive tract blockage (risk of tiny holes in the stomach and intestines).
2. Tiny holes in the intestinal tract (risk of complications, such as peritonitis, etc.).
3. Symptoms of toxic colitis (appearance of tiny holes that causes peritonitis and intestinal tract
bleeding).

DRUG INTERACTIONS
1. Administration of drug to patient who is using insulin or other diabetes drugs :
a. Avoid administering this drug prior to the day of examination.
b. The drug should be given on the day of examination under strict supervision.
c. Insulin or other diabetes drugs should be administered after meal on the day of examination.
2. Administration of this drug may probably cause the impediment in absorbing other drugs.

STORAGE
Stored at room temperature (15ºC - 30ºC).

PACKAGING
Box, one sachet @ 137.155 g
Reg. no.

Imported by :
PT MEIJI INDONESIAN
PHARMACEUTICAL INDUSTRIES
BANGIL-PASURUAN, JAWA TIMUR-INDONESIA
Manufactured by :
AJINOMOTO PHARMA CO., LTD
7 – 2, YAESU – CHOME, CHUO – KU
TOKYO 104 – 0028, JAPAN

Common questions

Powered by AI

In patients with renal function disorders, caution is advised because NIFLEC can induce side effects such as nausea and potential electrolyte imbalance. Close monitoring is necessary to avoid complications such as nephrotoxicity, and any symptoms of nausea or other adverse reactions should be promptly addressed. Physicians should assess the risks associated with increased fluid and electrolyte load in these patients .

Administering NIFLEC in elderly patients requires caution due to typically decreased biological functions. The drug should be administered slowly, under strict supervision to mitigate the risks of adverse effects, such as electrolyte imbalances or overhydration. It's crucial to adjust the dosage according to the patient's renal and hepatic status, ensuring the treatment's advantage surpasses potential risks .

Adding other substances or aromatic materials to NIFLEC can alter its osmotic pressure and electrolyte balance, risking the production of inflammable gases by intestinal bacteria. Such alterations can lead to reduced efficacy and increased risk of side effects, including intestinal inflammation and infection, justifying the need to prohibit additions to the solution .

NIFLEC can cause a range of side effects such as shock, anaphylaxis, nausea, vomiting, and abdominal pain. Management strategies include discontinuation of the drug and seeking medical intervention if symptoms such as hypotension, dizziness, or rash occur. Electrolyte imbalances from vomiting may require fluid and electrolyte replacement therapy. Monitoring for signs of shock or severe allergic reactions is critical, and administration should be under supervision when possible to manage any adverse effects promptly .

For diabetic patients, administering NIFLEC requires careful consideration due to potential hypoglycemia risks. It is advised to avoid the drug's use before an examination day, and to administer it under strict supervision on the day of examination. Insulin or other diabetes medications should only be given post-meal to prevent hypoglycemic episodes, acknowledging the carbohydrate-void state induced by fasting .

NIFLEC is contraindicated in patients with symptoms of digestive tract blockage, as its use can increase the risk of perforation or tiny holes forming in the stomach and intestines. It is also contraindicated in cases of known intestinal perforation and toxic colitis, where the drug could exacerbate peritonitis or intestinal bleeding. These conditions could lead to severe complications and require immediate medical attention, highlighting the need for thorough patient evaluation before administration .

NIFLEC acts primarily through its main ingredient, Macrogol 4000, which increases the volume of contents in the colon by retaining water, leading to the distension of the colon. This stimulates the stretch receptors in the colon, resulting in increased peristaltic movements, which produce a voluminous liquid stool. Additionally, the salts present in NIFLEC (Sodium Chloride, Sodium Sulfate, Potassium Chloride, and Sodium Bicarbonate) help prevent ion loss and absorption, maintaining electrolyte balance during bowel cleansing .

The timing and dietary restrictions prior to administering NIFLEC play a crucial role in ensuring its effectiveness. For instance, patients should fast and only drink fluids to enhance fluid balance and clear intestines. On the same day as a large intestine endoscopy, administration should begin four hours prior, with no breakfast consumed. Conversely, if administered the day before, fasting should start after dinner, with only liquid food permitted at dinner to reduce bowel content, thereby enhancing the effectiveness of bowel cleansing .

If there are no bowel movements after administering 2 liters of NIFLEC, the drug should be paused. The healthcare provider must ensure that the patient is not experiencing nausea, vomiting, or abdominal pain before resuming administration. Continuous monitoring of bowel movements is necessary, and further intake should only proceed after these symptoms have subsided, ensuring patient safety by avoiding unnecessary complications .

NIFLEC should be stored at room temperature, specifically between 15ºC and 30ºC. After being dissolved, the solution must ideally be used immediately or kept refrigerated for no more than 48 hours to maintain its efficacy. Deviating from these guidelines could compromise the drug's stability and potency .

You might also like